FarmavitaR+

regulatory affairs network

  • Increase font size
  • Default font size
  • Decrease font size

This section is about Pharmaceutical Business Reports.

Contributions from members are very welcome. Every article is published with full credentials about Author. Register as the member and publish your professional article.



Drug Repositioning Strategies

E-mail Print PDF

datamonitor_logo.gif

Drug Repositioning Strategies - Serendipity by design

Drug repositioning has several advantages over traditional discovery-reduced cost, risk and time to market-compared with traditional discovery, providing an attractive prospect for Big Pharma, scrambling to fill pipelines in an increasingly harsh market environment. As competition to inlicense candidates drives the price of this strategy up, repositioning presents a cost effective alternative.

Read more...
 


Page 3 of 6
Banner


Login With Facebook

Active Groups

{captcha}